A recent study attempts to add to the body of evidencethat is emerging regarding the fish oil parenteral lipidproduct Omegaven?. The authors have shown fromexpla
The current standard treatment option for advanced hepatocellular carcinoma(HCC) is sorafenib, but its clinical benefit is modest. In spite of many attempts, fe